Xenon Pharmaceuticals
XENE • NASDAQ
Xenon Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Andrea DiFabio, with a market cap of $5.4B.
Market Cap$5.4B
Employees259.0
CEOAndrea DiFabio
CountryCanada
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksAfter Market Close · Q1 2026
Financials
XEN
Xenon Pharmaceuticals FAQ
Common questions about Xenon Pharmaceuticals
Xenon Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 11, 2026 after market close. Analysts estimate revenue of $1.4M.
Xenon Pharmaceuticals has approximately 259 employees.